Qingdao Haier Biomedical Co Ltd (688139) - Total Liabilities

Latest as of December 2025: CN¥1.17 Billion CNY ≈ $170.96 Million USD

Based on the latest financial reports, Qingdao Haier Biomedical Co Ltd (688139) has total liabilities worth CN¥1.17 Billion CNY (≈ $170.96 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Qingdao Haier Biomedical Co Ltd (688139) cash flow conversion to assess how effectively this company generates cash.

Qingdao Haier Biomedical Co Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Qingdao Haier Biomedical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 688139 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Qingdao Haier Biomedical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Qingdao Haier Biomedical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Focus Technology Co Ltd SHE:002315	China	CN¥1.64 Billion
Qingdao Yunlu Advanced Materials Technology Co. Ltd. A SHG:688190	China	CN¥800.56 Million
Med Life SA RO:M	Romania	RON2.64 Billion
Blackrock Municipal Target Term Closed Fund NYSE:BTT	USA	$849.52 Million
Ruentex Industries Ltd TW:2915	Taiwan	NT$14.00 Billion
Edifier Technology Co Ltd SHE:002351	China	CN¥577.26 Million
Longkou Union Chemical Co. Ltd. A SHE:301209	China	CN¥205.12 Million
Sansure Biotech Inc SHG:688289	China	CN¥2.24 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Qingdao Haier Biomedical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Qingdao Haier Biomedical Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.45	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Qingdao Haier Biomedical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Qingdao Haier Biomedical Co Ltd (2016–2025)

The table below shows the annual total liabilities of Qingdao Haier Biomedical Co Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.17 Billion ≈ $170.96 Million	-0.09%
2024-12-31	CN¥1.17 Billion ≈ $171.11 Million	+7.70%
2023-12-31	CN¥1.09 Billion ≈ $158.87 Million	-19.02%
2022-12-31	CN¥1.34 Billion ≈ $196.18 Million	+6.31%
2021-12-31	CN¥1.26 Billion ≈ $184.54 Million	+8.89%
2020-12-31	CN¥1.16 Billion ≈ $169.46 Million	+99.30%
2019-12-31	CN¥581.08 Million ≈ $85.03 Million	-47.84%
2018-12-31	CN¥1.11 Billion ≈ $163.01 Million	+93.43%
2017-12-31	CN¥575.92 Million ≈ $84.28 Million	+154.31%
2016-12-31	CN¥226.46 Million ≈ $33.14 Million	--

About Qingdao Haier Biomedical Co Ltd

SHG:688139 China Medical Devices

Market Cap

$1.46 Billion

CN¥9.99 Billion CNY

Market Cap Rank

#7530 Global

#1832 in China

Share Price

CN¥31.56

Change (1 day)

+0.51%

52-Week Range

CN¥29.83 - CN¥36.98

All Time High

CN¥147.76